OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant

被引:29
作者
Erdile, LF
Guy, B
机构
[1] Pasteur Mérieux Connaught, 69280, Marcy L'Etoile
关键词
lipoprotein; mucosal; adjuvant;
D O I
10.1016/S0264-410X(96)00295-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The outer surface protein A (OspA) lipoprotein of Borrelia burgdorferi, like cholera toxin and the heat-labile enterotoxin of Escherichia coli, induces pro-inflammatory cytokines. This suggested that, like those toxins, OspA might be a mucosal immunogen and adjuvant. OspA, administered intranasally (i.n.) or intragastrically, induced strong serum IgG and salivary gland IgA responses. The serum IgG isotypes were indicative of a mixed T helper 1 and T helper 2 response, the latter being more pronounced. The N-terminal tripalmitoyl-S-glyceryl-cysteine (Pam(3)Cys) lipid moiety was absolutely required. OspA strongly enhanced the serum IgG and salivary gland IgA responses to jack bean urease co-administered by the i.n. route. OspA also enhanced the response to tetanus toroid and induced limited protection against challenge. A synthetic lipopeptide also adjuvanted the response to urease by the i.n. route, but teas ca 500-fold less potent on a molar basis than OspA. These results suggest that OspA or other lipoproteins may be useful in mucosal vaccines. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:988 / 995
页数:8
相关论文
共 35 条
[1]   SPECIFIC ANTIBODIES ELICITED BY ANTIGEN COVALENTLY LINKED TO A SYNTHETIC ADJUVANT [J].
BESSLER, WG ;
SUHR, B ;
BUHRING, HJ ;
MULLER, CP ;
WIESMULLER, KH ;
BECKER, G ;
JUNG, G .
IMMUNOBIOLOGY, 1985, 170 (03) :239-244
[2]   IMMUNOGENIC INTEGRAL MEMBRANE-PROTEINS OF BORRELIA-BURGDORFERI ARE LIPOPROTEINS [J].
BRANDT, ME ;
RILEY, BS ;
RADOLF, JD ;
NORGARD, MV .
INFECTION AND IMMUNITY, 1990, 58 (04) :983-991
[3]  
BROMANDER A, 1991, J IMMUNOL, V146, P2908
[4]  
Bromander AK, 1996, J IMMUNOL, V156, P4290
[5]   RECOMBINANT OSPA PROTECTS DOGS AGAINST INFECTION AND DISEASE CAUSED BY BORRELIA-BURGDORFERI [J].
CHANG, YF ;
APPEL, MJG ;
JACOBSON, RH ;
SHIN, SJ ;
HARPENDING, P ;
STRAUBINGER, R ;
PATRICAN, LA ;
MOHAMMED, H ;
SUMMERS, BA .
INFECTION AND IMMUNITY, 1995, 63 (09) :3543-3549
[6]   MACROMOLECULAR ASSEMBLAGE IN THE DESIGN OF A SYNTHETIC AIDS VACCINE [J].
DEFOORT, JP ;
NARDELLI, B ;
HUANG, WL ;
HO, DD ;
TAM, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3879-3883
[7]   INVIVO PRIMING OF VIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T WITH SYNTHETIC LIPOPEPTIDE VACCINE [J].
DERES, K ;
SCHILD, H ;
WIESMULLER, KH ;
JUNG, G ;
RAMMENSEE, HG .
NATURE, 1989, 342 (6249) :561-564
[8]   MUTANTS OF ESCHERICHIA-COLI HEAT-LABILE TOXIN LACKING ADP-RIBOSYLTRANSFERASE ACTIVITY ACT AS NONTOXIC, MUCOSAL ADJUVANTS [J].
DOUCE, G ;
TURCOTTE, C ;
CROPLEY, I ;
ROBERTS, M ;
PIZZA, M ;
DOMENGHINI, M ;
RAPPUOLI, R ;
DOUGAN, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1644-1648
[9]  
Dunn J J, 1990, Protein Expr Purif, V1, P159, DOI 10.1016/1046-5928(90)90011-M
[10]   ROLE OF ATTACHED LIPID IN IMMUNOGENICITY OF BORRELIA-BURGDORFERI OSPA [J].
ERDILE, LF ;
BRANDT, MA ;
WARAKOMSKI, DJ ;
WESTRACK, GJ ;
SADZIENE, A ;
BARBOUR, AG ;
MAYS, JP .
INFECTION AND IMMUNITY, 1993, 61 (01) :81-90